The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
An Inhibitor of Nonhomologous End-Joining Abrogates Double-Strand Break Repair and Impedes Cancer Progression
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One of the most commonly used inhibitors, Scr7, targets the NHEJ component DNA ligase IV, and has been reported to increase efficiency of HDR from Cas9 editing by up to 19-fold (Srivastava et al., 2012; Chu et al., 2015; Vartak & Raghavan, 2015).”
From Delivering CRISPR: a review of the challenges and approaches (2018) · cites this paper as Srivastava et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved tools for biological sequence comparison.
Pearson, W. R., & Lipman, D. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2444 · Cited by 11,227
The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway
Lieber, M. R. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.052308.093131 · Cited by 2,882
Zhu, C., Mills, K. D., Ferguson, D. O., Lee, C., Manis, J., Fleming, J., Gao, Y., Morton, C. C., & Alt, F. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00770-5 · Cited by 421 · cited 1×
“, resulting in oncogenic transformations or cell death (Nambiar and Raghavan, 2011; Zhu et al., 2002).”
Research works printed but not linked: 56
- Adamo, 2010, Preventing nonhomologous end joining suppresses DNA repair defects of Fanconi anemia, Mol. Cell, 39, 25, 10.1016/j.molcel.2010.06.026 · DOI · Paper page
- Banin, 1998, Enhanced phosphorylation of p53 by ATM in response to DNA damage, Science, 281, 1674, 10.1126/science.281.5383.1674 · DOI · Paper page
- Begg, 2011, Strategies to improve radiotherapy with targeted drugs, Nat. Rev. Cancer, 11, 239, 10.1038/nrc3007 · DOI · Paper page
- Bennardo, 2008, Alternative-NHEJ is a mechanistically distinct pathway of mammalian chromosome break repair, PLoS Genet., 4, e1000110, 10.1371/journal.pgen.1000110 · DOI · Paper page
- Chen, 2008, Rational design of human DNA ligase inhibitors that target cellular DNA replication and repair, Cancer Res., 68, 3169, 10.1158/0008-5472.CAN-07-6636 · DOI · Paper page
- Ellenberger, 2008, Eukaryotic DNA ligases: structural and functional insights, Annu. Rev. Biochem., 77, 313, 10.1146/annurev.biochem.77.061306.123941 · DOI · Paper page
- Ferguson, 2000, The nonhomologous end-joining pathway of DNA repair is required for genomic stability and the suppression of translocations, Proc. Natl. Acad. Sci. USA, 97, 6630, 10.1073/pnas.110152897 · DOI · Paper page
- Frank, 1998, Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV, Nature, 396, 173, 10.1038/24172 · DOI · Paper page
- Frank, 2000, DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway, Mol. Cell, 5, 993, 10.1016/S1097-2765(00)80264-6 · DOI · Paper page
- Gao, 1998, A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis, Cell, 95, 891, 10.1016/S0092-8674(00)81714-6 · DOI · Paper page
- Gostissa, 2011, Mechanisms that promote and suppress chromosomal translocations in lymphocytes, Annu. Rev. Immunol., 29, 319, 10.1146/annurev-immunol-031210-101329 · DOI
- Gu, 2007, XRCC4:DNA ligase IV can ligate incompatible DNA ends and can ligate across gaps, EMBO J., 26, 1010, 10.1038/sj.emboj.7601559 · DOI · Paper page
- Jayaram, 2008, Loss of DNA ligase IV prevents recognition of DNA by double-strand break repair proteins XRCC4 and XLF, Nucleic Acids Res., 36, 5773, 10.1093/nar/gkn552 · DOI
- Kumar, 2010, Anti-apoptotic protein BCL2 down-regulates DNA end joining in cancer cells, J. Biol. Chem., 285, 32657, 10.1074/jbc.M110.140350 · DOI
- Kuschel, 2002, Variants in DNA double-strand break repair genes and breast cancer susceptibility, Hum. Mol. Genet., 11, 1399, 10.1093/hmg/11.12.1399 · DOI · Paper page
- Mao, 2008, DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells, Cell Cycle, 7, 2902, 10.4161/cc.7.18.6679 · DOI · Paper page
- Nambiar, 2011, How does DNA break during chromosomal translocations?, Nucleic Acids Res., 39, 5813, 10.1093/nar/gkr223 · DOI
- Nick McElhinny, 2000, Ku recruits the XRCC4-ligase IV complex to DNA ends, Mol. Cell. Biol., 20, 2996, 10.1128/MCB.20.9.2996-3003.2000 · DOI
- Pace, 2010, Ku70 corrupts DNA repair in the absence of the Fanconi anemia pathway, Science, 329, 219, 10.1126/science.1192277 · DOI · Paper page
- Pascal, 2004, Human DNA ligase I completely encircles and partially unwinds nicked DNA, Nature, 432, 473, 10.1038/nature03082 · DOI · Paper page
- Pucci, 2001, Tumor specific modulation of KU70/80 DNA binding activity in breast and bladder human tumor biopsies, Oncogene, 20, 739, 10.1038/sj.onc.1204148 · doi:10.1038/sj.onc.1204148
- Riballo, 1999, Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient, Curr. Biol., 9, 699, 10.1016/S0960-9822(99)80311-X · DOI · Paper page
- Sallmyr, 2008, Up-regulation of WRN and DNA ligase IIIalpha in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks, Blood, 112, 1413, 10.1182/blood-2007-07-104257 · DOI
- Sathees, 1999, Mouse testicular extracts process DNA double-strand breaks efficiently by DNA end-to-end joining, Mutat. Res., 433, 1, 10.1016/S0921-8777(98)00055-X · DOI
- Sharma, 2010, Nonhomologous DNA end joining in cell-free extracts, J. Nucleic Acids, 2010, 10.4061/2010/389129 · DOI
- Sharma, 2011, Efficiency of nonhomologous DNA end joining varies among somatic tissues, despite similarity in mechanism, Cell. Mol. Life Sci., 68, 661, 10.1007/s00018-010-0472-x · DOI
- Shintani, 2003, Up-regulation of DNA-dependent protein kinase correlates with radiation resistance in oral squamous cell carcinoma, Cancer Sci., 94, 894, 10.1111/j.1349-7006.2003.tb01372.x · DOI
- Sibanda, 2001, Crystal structure of an Xrcc4-DNA ligase IV complex, Nat. Struct. Biol., 8, 1015, 10.1038/nsb725 · DOI
- Simsek, 2010, Alternative end-joining is suppressed by the canonical NHEJ component Xrcc4-ligase IV during chromosomal translocation formation, Nat. Struct. Mol. Biol., 17, 410, 10.1038/nsmb.1773 · DOI · Paper page
- Sirzén, 1999, DNA-dependent protein kinase content and activity in lung carcinoma cell lines: correlation with intrinsic radiosensitivity, Eur. J. Cancer, 35, 111, 10.1016/S0959-8049(98)00289-5 · DOI
- Zapata, 1998, Expression of multiple apoptosis-regulatory genes in human breast cancer cell lines and primary tumors, Breast Cancer Res. Treat., 47, 129, 10.1023/A:1005940832123 · DOI
- Zhang, 2010, Selective targeting of radiation-resistant tumor-initiating cells, Proc. Natl. Acad. Sci. USA, 107, 3522, 10.1073/pnas.0910179107 · DOI · Paper page
- Chen, X., Pascal, J., Vijayakumar, S., Wilson, G.M., Ellenberger, T., and Tomkinson, A.E. (2006). Human DNA ligases I, III, and IV-purification and new specific assays for these enzymes. Methods Enzymol. 409, 39–52. · DOI
- Chiruvella, K.K., Kari, V., Choudhary, B., Nambiar, M., Ghanta, R.G., and Raghavan, S.C. (2008). Methyl angolensate, a natural tetranortriterpenoid induces intrinsic apoptotic pathway in leukemic cells. FEBS Lett. 582, 4066–4076. · DOI
- De, A., Yaghoubi, S.S., and Gambhir, S.S. (2008). Applications of Lentiviral Vectors in Non-invasive Molecular Imaging. Methods Mol. Biol. 433, 177–202. · DOI
- Furlan, R.L.A., Garrido, L.M., Brumatti, G., Amarante-Mendes, G.P., Martins, R.A., Facciotti, M.C.R., and Padillo, G. (2002). A rapid and sensitive method for the screening of DNA intercalating antibiotics. Biotechnol. Lett. 24, 1807–1813. · doi:10.1023/a:1020633909762
- Ghosh, M., Bhattacharya, S., Sadhu, U., Dutta, S., and Sanyal, U. (1997). Evaluation of beta-tethymustine, a new anticancer compound, in murine tumour models. Cancer Lett. 119, 7–12. · doi:10.1016/s0304-3835(97)00244-9
- Hanakahi, L.A. (2007). 2-Step purification of the Ku DNA repair protein expressed in Escherichia coli. Protein Expr. Purif. 52, 139–145. · DOI
- Hazra, B., Kumar, B., Biswas, S., Pandey, B.N., and Mishra, K.P. (2005). Enhancement of the tumour inhibitory activity, in vivo, of diospyrin, a plant-derived quinonoid, through liposomal encapsulation. Toxicol. Lett. 157, 109–117. · doi:10.1016/j.toxlet.2005.01.016
- Kavitha, C.V., Nambiar, M., Ananda Kumar, C.S., Choudhary, B., Muniyappa, K., Rangappa, K.S., and Raghavan, S.C. (2009). Novel derivatives of spirohydantoin induce growth inhibition followed by apoptosis in leukemia cells. Biochem. Pharmacol. 77, 348–363. · DOI
- Kumagai, H., Mukaisho, K., Sugihara, H., Miwa, K., Yamamoto, G., and Hattori, T. (2004). Thioproline inhibits development of esophageal adenocarcinoma induced by gastroduodenal reflux in rats. Carcinogenesis 25, 723–727. · DOI
- Kumar, T.S., Kari, V., Choudhary, B., Nambiar, M., Akila, T.S., and Raghavan, S.C. (2010). Anti-apoptotic protein BCL2 down-regulates DNA end joining in cancer cells. J. Biol. Chem. 285, 32657–32670. · DOI
- Kuntz, I.D., Blaney, J.M., Oatley, S.J., Langridge, R., and Ferrin, T.E. (1982). A geometric approach to macromolecule-ligand interactions. J. Mol. Biol. 161, 269–288. · DOI · Paper page
- Ma, Y., Lu, H., Tippin, B., Goodman, M.F., Shimazaki, N., Koiwai, O., Hsieh, C.L., Schwarz, K., and Lieber, M.R. (2004). A biochemically defined system for mammalian nonhomologous DNA end joining. Mol. Cell 16, 701–713. · DOI · Paper page
- Modesti, M., Hesse, J.E., and Gellert, M. (1999). DNA binding of Xrcc4 protein is associated with V(D)J recombination but not with stimulation of DNA ligase IV activity. EMBO J. 18, 2008–2018. · DOI · Paper page
- Nambiar, M., and Raghavan, S.C. (2010). Prevalence and analysis of t(14;18) and t(11;14) chromosomal translocations in healthy Indian population. Ann. Hematol. 89, 35–43. · DOI
- Noaman, E., Badr El-Din, N.K., Bibars, M.A., Abou Mossallam, A.A., and Ghoneum, M. (2008). Antioxidant potential by arabinoxylan rice bran, MGN-3/biobran, represents a mechanism for its oncostatic effect against murine solid Ehrlich carcinoma. Cancer Lett. 268, 348–359. · DOI
- Osner, W.M., Castle, R.N., and Aldous, D.L. (1963). Pyridazines. I. 4-Halo-5-hydrazino-3-pyridazone and its derivatives. J. Pharm. Sci. 52, 539–541. · doi:10.1002/jps.2600520605
- Pettersen, E.F., Goddard, T.D., Huang, C.C., Couch, G.S., Greenblatt, D.M., Meng, E.C., and Ferrin, T.E. (2004). UCSF Chimera—a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612. · DOI · Paper page
- Raghavan, S.C., and Raman, M.J. (2004). Nonhomologous end joining of complementary and noncomplementary DNA termini in mouse testicular extracts. DNA Repair (Amst.) 3, 1297–1310. · DOI
- Roy, A., Kucukural, A., and Zhang, Y. (2010). I-TASSER: a unified platform for automated protein structure and function prediction. Nat. Protoc. 5, 725–738. · DOI · Paper page
- Sathees, C.R., and Raman, M.J. (1999). Mouse testicular extracts process DNA double-strand breaks efficiently by DNA end-to-end joining. Mutat. Res. 433, 1–13. · DOI
- Shahabuddin, M.S., Nambiar, M., Choudhary, B., Advirao, G.M., and Raghavan, S.C. (2010). A novel DNA intercalator, butylamino-pyrimido[4′,5′:4,5]selenolo(2,3-b)quinoline, induces cell cycle arrest and apoptosis in leukemic cells. Invest. New Drugs 28, 35–48. · DOI
- Sharma, S., Choudhary, B., and Raghavan, S.C. (2011). Efficiency of nonhomologous DNA end joining varies among somatic tissues, despite similarity in mechanism. Cell. Mol. Life Sci. 68, 661–676. · DOI
- Sharma, S., Panjamurthy, K., Choudhary, B., Srivastava, M., Shahabuddin, M., Giri, R., Advirao, G.M., and Raghavan, S.C. (2012). A novel DNA intercalator, 8-methoxy pyrimido[4’,5′:4,5]thieno (2,3-b)quinoline-4(3H)-one induces apoptosis in cancer cells, inhibits the tumor progression and enhances lifespan in mice with tumor. Mol Carcinog. Published online December 28, 2011. http://dx.doi.org/10.1002/mc.21867. · doi:10.1002/mc.21867
- Wheater, P.R., Burkitt, H.G., and Daniels, V.G. (1987). Functional Histology: A Text and Colour Atlas, Second Edition (London: Churchill Livingstone).
Cited by
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
Anzalone, A. V., Koblan, L. W., & Liu, D. R. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0561-9 · Cited by 2,237
Chu, V. T., Weber, T., Wefers, B., Wurst, W., Sander, S., Rajewsky, K., & Kühn, R. (2015) · Nature Biotechnology · doi:10.1038/nbt.3198 · Cited by 1,210
DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
Huang, R.-X., & Zhou, P.-K. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0150-x · Cited by 1,198
Delivering CRISPR: a review of the challenges and approaches
Lino, C. A., Harper, J. C., Carney, J. P., & Timlin, J. A. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1474964 · Cited by 1,185
Maruyama, T., Dougan, S. K., Truttmann, M. C., Bilate, A. M., Ingram, J. R., & Ploegh, H. L. (2015) · Nature Biotechnology · doi:10.1038/nbt.3190 · Cited by 1,137
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
Komor, A. C., Badran, A. H., & Liu, D. R. (2017) · Cell · doi:10.1016/j.cell.2016.10.044 · Cited by 1,013
Huang, R., & Zhou, P.-K. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00648-7 · Cited by 907
Srivastava, S., Somasagara, R. R., Hegde, M., Nishana, M., Tadi, S. K., Srivastava, M., Choudhary, B., & Raghavan, S. C. (2016) · Scientific Reports · doi:10.1038/srep24049 · Cited by 483
Self-citationSmall molecules enhance CRISPR genome editing in pluripotent stem cells
Yu, C., Liu, Y., Ma, T., Liu, K., Xu, S., Zhang, Y., Liu, H., La Russa, M., Xie, M., Ding, S., et al. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.01.003 · Cited by 455
Modernizing the Nonhomologous End-Joining Repertoire: Alternative and Classical NHEJ Share the Stage
Deriano, L., & Roth, D. B. (2013) · Annual Review of Genetics · doi:10.1146/annurev-genet-110711-155540 · Cited by 453
DNA Repair Pathway Choices in CRISPR-Cas9-Mediated Genome Editing
Xue, C., & Greene, E. C. (2021) · Trends in Genetics · doi:10.1016/j.tig.2021.02.008 · Cited by 431
RS-1 enhances CRISPR/Cas9- and TALEN-mediated knock-in efficiency
Song, J., Yang, D., Xu, J., Zhu, T., Chen, Y. E., & Zhang, J. (2016) · Nature Communications · doi:10.1038/ncomms10548 · Cited by 422
Advances in genome editing through control of DNA repair pathways
Yeh, C. D., Richardson, C. D., & Corn, J. E. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0425-z · Cited by 405
DNA repair targeted therapy: The past or future of cancer treatment?
Gavande, N. S., VanderVere-Carozza, P. S., Hinshaw, H. D., Jalal, S. I., Sears, C. R., Pawelczak, K. S., & Turchi, J. J. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.02.003 · Cited by 387
End-joining, translocations and cancer
Bunting, S. F., & Nussenzweig, A. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3537 · Cited by 359
Methodologies for Improving HDR Efficiency
Liu, M., Rehman, S., Tang, X., Gu, K., Fan, Q., Chen, D., & Ma, W. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2018.00691 · Cited by 323
A Mouse Geneticist’s Practical Guide to CRISPR Applications
Singh, P., Schimenti, J. C., & Bolcun-Filas, E. (2015) · Genetics · doi:10.1534/genetics.114.169771 · Cited by 305
Post-translational Regulation of Cas9 during G1 Enhances Homology-Directed Repair
Gutschner, T., Haemmerle, M., Genovese, G., Draetta, G. F., & Chin, L. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.019 · Cited by 299
Targeting DNA damage response in cancer therapy
Hosoya, N., & Miyagawa, K. (2014) · Cancer Science · doi:10.1111/cas.12366 · Cited by 294
Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches
Dietlein, F., Thelen, L., & Reinhardt, H. C. (2014) · Trends in Genetics · doi:10.1016/j.tig.2014.06.003 · Cited by 280
Pinder, J., Salsman, J., & Dellaire, G. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv993 · Cited by 279
Canny, M. D., Moatti, N., Wan, L. C. K., Fradet-Turcotte, A., Krasner, D., Mateos-Gomez, P. A., Zimmermann, M., Orthwein, A., Juang, Y.-C., Zhang, W., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4021 · Cited by 271
Potential pitfalls of CRISPR/Cas9‐mediated genome editing
Peng, R., Lin, G., & Li, J. (2016) · The FEBS Journal · doi:10.1111/febs.13586 · Cited by 213
Generation and validation of homozygous fluorescent knock-in cells using CRISPR-Cas9 genome editing
Koch, B., Nijmeijer, B., Kueblbeck, M., Cai, Y., Walther, N., & Ellenberg, J. (2018) · Nature Protocols · doi:10.1038/nprot.2018.042 · Cited by 134
Gaj, T., Staahl, B. T., Rodrigues, G. M. C., Limsirichai, P., Ekman, F. K., Doudna, J. A., & Schaffer, D. V. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx154 · Cited by 89
Revisiting CRISPR/Cas-mediated crop improvement: special focus on nutrition
Kaul, T., Sony, S. K., Verma, R., Motelb, K. F. A., Prakash, A. T., Eswaran, M., Bharti, J., Nehra, M., & Kaul, R. (2020) · Journal of Biosciences · doi:10.1007/s12038-020-00094-7 · Cited by 33
Metadata
- Authors
- Srivastava, M., Nambiar, M., Sharma, S., Karki, S. S., Goldsmith, G., Hegde, M., Kumar, S., Pandey, M., Singh, R. K., Ray, P., Natarajan, R., Kelkar, M., De, A., Choudhary, B., & Raghavan, S. C.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2012-12
- Volume
- 151
- Issue
- 7
- Pages
- 1474-1487
- ISSN
- 0092-8674
- Cited by
- 355
- References
- 3
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 385 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.